Skip to main content
Clinical Trials/CTRI/2023/10/058368
CTRI/2023/10/058368
Not yet recruiting
Phase 2

Randomized controlled clinical study to evaluate the efficacy of Trikatu Ghanawati in Sthaulya with special reference to Overweight subjects - NI

Dr Shravani Parate0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E660- Obesity due to excess calories
Sponsor
Dr Shravani Parate
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Shravani Parate

Eligibility Criteria

Inclusion Criteria

  • patient having BMI ranging between 25\-29\.9 kg/m2 i.e., overweight
  • 2\) Patient between age group 20\-50 yrs , irrespective of gender.
  • 3\) Patient having sign and symptoms of sthaulya Kshudra Shwas, Kshudhatimatra,
  • Pipasadhikya, Swedadhikya, Atinidra,Daurgandhya, Daurbalya.

Exclusion Criteria

  • EXCLUSION CRITERIA–
  • 1\. BMI \<25 and \>30
  • 2\. Patients is known case of cardiac , pulmonary renal and hepatic diseases, etc.
  • 3\. Patients having medical emergencies associated with like Coronary Heart
  • disease, Atherosclerosis, Myocardial infarction etc.
  • 4\. Pregnant females and lactating women’s.
  • 5\. Patients having history of diabetic mellitus , thyroid disorder and HTN, and
  • other endocrine disease.
  • 6\. Overweight due to drug eg. \- corticosteroids.
  • 7\. Patients is suffering from peptic ulcer disorder, bledding disorder were

Outcomes

Primary Outcomes

Not specified

Similar Trials